AngioDynamics (ANGO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
July 16, 2015 4:01 PM EDTFourth quarter fiscal 2015 net sales of $90.9 million; Full year net sales of $357 million Fourth quarter fiscal 2015 GAAP loss of $0.02 per share; Non-GAAP adjusted net income of $0.14 per share; full year non-GAAP adjusted income of $0.58 per share Fourth quarter fiscal 2015 operating cash generation of $10.8 million; Full year operating cash generation of $26.2 million Preliminary FY2016 guidance of 2% - 4% sales growth and 7% - 14% adjusted EPS growth
ALBANY, N.Y., July 16, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider... More
